Jiangsu Hengrui Pharmaceuticals Co., Ltd. (0BO)
FSX
Real-time Data
06:00 AM
Day's Range
5.1052 wk Range
5.10Overview - 0BO - Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Key Statistics
Valuation
Enterprise Value
71.61M
P/E (Trailing)
‪34.66‬
Price / Sales (TTM)
‪1.05‬
Price / Book
‪4.35‬
EV / EBITDA
‪0.06‬
Profitability
Gross Margin
‪86.59%‬
Profit Margin
‪24.93%‬
Operating Margin
‪31.56%‬
Return on Assets
‪8.80%‬
Return on Equity
‪14.54%‬
Ownership
Shares Outstanding
6.63B
Float
3.77B
Held by Insiders
‪0.00%‬
Held by Institutions
‪71.27%‬
Price stats
Beta
‪0.04‬
50-Day Avg
‪6.23‬
200-Day Avg
‪7.04‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 0BO - Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Peers - 0BO - Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on FSX.
- 0BOFSXJiangnan Group Limited34.51BMarket Cap-61.54%52-week change33.44P/E (Trailing)‪24.93%‬Profit Margin
- LLYFSXEli Lilly and Company967.12BMarket Cap+44.42%52-week change42.55P/E (Trailing)‪33.52%‬Profit Margin
- LLY0FSXEli Lilly CDR862.66BMarket Cap+42.05%52-week change37.71P/E (Trailing)‪33.52%‬Profit Margin
- JNJFSXJohnson & Johnson559.57BMarket Cap+33.87%52-week change31.59P/E (Trailing)‪21.48%‬Profit Margin
- JNJ0FSXJohnson & Johnson CDR515.60BMarket Cap+32.69%52-week change28.49P/E (Trailing)‪21.48%‬Profit Margin
- 4AB0FSXAbbVie Inc. CDR404.07BMarket Cap+27.27%52-week change75.63P/E (Trailing)‪9.80%‬Profit Margin
- 4ABFSXAbbVie Inc.400.95BMarket Cap+21.11%52-week change75.13P/E (Trailing)‪9.80%‬Profit Margin
Profile Summary - 0BO - Jiangsu Hengrui Pharmaceuticals Co., Ltd.
About
Jiangnan Group Limited is an investment holding company principally engaged in the manufacture and trading of wires and cables in the People's Republic of China. It operates through four main segments: power cables for transmission and distribution systems, wires and cables for electrical equipment used in industrial…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
